XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.clinicaltrialsarena.com/news/biopharmx-secures-irb-approval-start-phase-ll-trial-bpx-04/20%Daily2018-07-31 23:00
https://www.clinicaltrialsarena.com/news/arcus-receives-approval-start-phase-l-trial-ab154/20%Daily2018-07-31 23:00
https://www.clinicaltrialsarena.com/news/teva-reports-negative-data-legato-hd-trial/20%Daily2018-07-31 23:00
https://www.clinicaltrialsarena.com/comment/biopharmaceuticals-dach-region-availability-patients-austria-germany-switzerland/20%Daily2018-12-03 12:09
https://www.clinicaltrialsarena.com/news/opthea-doses-first-patient-phase-lla-study-opt-302-dme/20%Daily2018-07-30 23:00
https://www.clinicaltrialsarena.com/news/kyoto-university-begin-new-trials-ips-cells-treat-parkinsons/20%Daily2018-07-30 23:00
https://www.clinicaltrialsarena.com/news/regeneus-reports-positive-results-activate-trial-rgsh4k/20%Daily2018-07-30 23:00
https://www.clinicaltrialsarena.com/analysis/expert-insights-future-drug-discovery-looks-hands-artificial-intelligence/20%Daily2019-08-08 09:43
https://www.clinicaltrialsarena.com/news/phase-3-trial-subcutaneous-pertuzumab-trastuzumab-begins-using-halozymes-enhanze-technology/20%Daily2018-07-29 23:00
https://www.clinicaltrialsarena.com/news/ultragenyx-first-patient-phase-1-2-study-dtx401-treat-gsdia/20%Daily2018-07-29 23:00
https://www.clinicaltrialsarena.com/news/ema-issues-positive-opinion-biomarker-parkinsons-trials/20%Daily2018-07-29 23:00
https://www.clinicaltrialsarena.com/news/tolero-doses-first-patient-phase-l-trial-tp-0184/20%Daily2018-07-26 23:00
https://www.clinicaltrialsarena.com/news/company-news/mas-week-nabriva-therapeutics-sangamo-therapeutics-ryboquin/20%Daily2019-08-12 09:38
https://www.clinicaltrialsarena.com/news/company-news/deals-week-verastem-caladrius-biosciences-reata-pharmaceuticals/20%Daily2018-07-26 23:00
https://www.clinicaltrialsarena.com/news/neurovia-starts-phase-l-ll-trial-of-nv1205-for-ccald/20%Daily2018-07-26 23:00
https://www.clinicaltrialsarena.com/news/chiasma-ends-enrolment-mpowered-trial-acromegaly/20%Daily2018-07-26 23:00
https://www.clinicaltrialsarena.com/news/nih-extends-neuronext-neurological-clinical-research-five-years/20%Daily2018-07-25 23:00
https://www.clinicaltrialsarena.com/news/aldeyra-enrols-first-patient-phase-lll-trial-reproxalap/20%Daily2018-07-25 23:00
https://www.clinicaltrialsarena.com/news/biohaven-initiates-phase-2-3-clinical-trial-trigriluzole-alzheimers-disease/20%Daily2018-07-25 23:00
https://www.clinicaltrialsarena.com/uncategorized/britain-needs-improve-data-skills-survive-post-brexit/20%Daily2018-07-25 15:17
https://www.clinicaltrialsarena.com/uncategorized/intelligent-automation-boost-global-financial-revenue-500bn-2020/20%Daily2018-07-25 15:16
https://www.clinicaltrialsarena.com/uncategorized/two-companies-using-ai-treat-orphan-diseases/20%Daily2018-07-25 15:08
https://www.clinicaltrialsarena.com/uncategorized/ai-will-force-millions-switch-careers-next-two-decades-pwc/20%Daily2018-07-25 15:07
https://www.clinicaltrialsarena.com/uncategorized/smishing-guide-latest-cyber-threat/20%Daily2018-07-25 15:06
https://www.clinicaltrialsarena.com/uncategorized/cryptocurrency-regulation-uk-enough/20%Daily2018-07-25 15:05
https://www.clinicaltrialsarena.com/uncategorized/great-firewall-china-digital-economy-thrives-despite-robust-internet-regulations/20%Daily2018-07-25 15:00
https://www.clinicaltrialsarena.com/uncategorized/ai-space-augmentation-future-according-serial-tech-investor/20%Daily2018-07-25 14:51
https://www.clinicaltrialsarena.com/news/leap-merck-pfizer-partner-start-phase-ii-trial-tumours/20%Daily2018-07-24 23:00
https://www.clinicaltrialsarena.com/news/agtc-enrols-first-patient-second-cohort-xlrp-trial/20%Daily2018-07-24 23:00
https://www.clinicaltrialsarena.com/news/beigene-doses-first-patient-phase-lll-trial-tislelizumab/20%Daily2018-07-24 23:00
https://www.clinicaltrialsarena.com/news/enriched-evidence-generation-linking-clinical-data-registries-patient-reported-outcomes-health-care-utilization/20%Daily2018-12-10 15:29
https://www.clinicaltrialsarena.com/news/sangamo-treats-first-patient-empowers-study-sb-318/20%Daily2018-07-23 23:00
https://www.clinicaltrialsarena.com/news/chi-med-begins-phase-ib-ii-trial-sulfatinib-us/20%Daily2018-07-23 23:00
https://www.clinicaltrialsarena.com/news/immunicum-receives-approval-phase-ib-ii-trial-ilixadencel-cpi/20%Daily2018-07-23 23:00
https://www.clinicaltrialsarena.com/news/takeda-reports-positive-top-line-outcomes-visible-1-trial/20%Daily2018-07-22 23:00
https://www.clinicaltrialsarena.com/news/bristol-myers-squibb-gritstone-start-phase-l-trial-tumours/20%Daily2018-07-22 23:00
https://www.clinicaltrialsarena.com/news/roche-reports-positive-interim-data-mpower132-trial/20%Daily2018-07-22 23:00
https://www.clinicaltrialsarena.com/comment/impact-gene-cell-therapy-supply-chain/20%Daily2018-12-10 15:32
https://www.clinicaltrialsarena.com/analysis/stemgene-therapy-consideration/20%Daily2019-08-08 09:43
https://www.clinicaltrialsarena.com/news/asana-starts-phase-llb-trial-asn002-atopic-dermatitis/20%Daily2019-08-07 13:57
https://www.clinicaltrialsarena.com/news/pfizer-lilly-report-positive-results-phase-lll-trial-tanezumab/20%Daily2018-07-19 23:00
https://www.clinicaltrialsarena.com/news/deals-mas-week-pliant-therapeutics-molmed-modus-therapeutics/20%Daily2019-08-12 09:38
https://www.clinicaltrialsarena.com/news/abivax-completes-dosing-in-abx464-101-trial-for-uc/20%Daily2018-07-19 23:00
https://www.clinicaltrialsarena.com/comment/heres-medicine-maam/20%Daily2018-12-10 15:38
https://www.clinicaltrialsarena.com/news/blade-therapeutics-starts-phase-l-trial-of-bld-2660-for-fibrosis/20%Daily2018-07-18 23:00
https://www.clinicaltrialsarena.com/news/eisai-reports-positive-topline-results-camellia-timi61-trial/20%Daily2018-07-18 23:00
https://www.clinicaltrialsarena.com/news/takeda-ovid-partner-start-three-clinical-trials-tak-935-ov935/20%Daily2018-07-18 23:00
https://www.clinicaltrialsarena.com/comment/arrival-gene-therapy-personalized-medicine/20%Daily2018-12-10 15:39
https://www.clinicaltrialsarena.com/news/concentric-starts-phase-ll-trial-ca-008-post-surgical-pain/20%Daily2018-07-17 23:00
https://www.clinicaltrialsarena.com/news/janssen-ends-credence-trial-early-after-meeting-efficacy-goals/20%Daily2018-07-17 23:00
https://www.clinicaltrialsarena.com/news/som-biotech-begins-phase-lla-trial-som3355/20%Daily2018-07-17 23:00
https://www.clinicaltrialsarena.com/analysis/scientific-breakthroughs-treating-cinv-helping-patients-cope-cancer-treatments/20%Daily2019-08-08 09:43
https://www.clinicaltrialsarena.com/news/pfizer-starts-phase-lll-trial-fidanacogene-elaparvovec/20%Daily2018-07-16 23:00
https://www.clinicaltrialsarena.com/news/ironwood-starts-phase-iiib-trial-linaclotide-ibs-c/20%Daily2018-07-16 23:00
https://www.clinicaltrialsarena.com/news/maxcyte-receives-fda-approval-start-phase-study-mcy-m11/20%Daily2018-07-16 23:00
https://www.clinicaltrialsarena.com/news/targovax-doses-first-patient-phase-ii-trial-oncos-102-dcvac/20%Daily2018-07-15 23:00
https://www.clinicaltrialsarena.com/news/cohbar-starts-phase-la-lb-trial-cb4211-nash-obesity/20%Daily2018-07-15 23:00
https://www.clinicaltrialsarena.com/news/xencor-doses-first-patient-duet-2-trial-xmab20717/20%Daily2018-07-15 23:00
https://www.clinicaltrialsarena.com/comment/fundamentals-robust-cold-chain-strategy/20%Daily2018-12-10 15:43
https://www.clinicaltrialsarena.com/news/deals-week-idorsia-assembly-biosciences-cytomx-therapeutics/20%Daily2018-07-12 23:00
https://www.clinicaltrialsarena.com/news/janssen-reports-negative-results-phoenix-trial/20%Daily2018-07-12 23:00
https://www.clinicaltrialsarena.com/news/landos-doses-first-subject-cohort-phase-l-trial-bt-11-ibd/20%Daily2018-07-12 23:00
https://www.clinicaltrialsarena.com/news/ludwig-cancer-research-cri-start-phase-ii-trial-cancer/20%Daily2018-07-12 23:00
https://www.clinicaltrialsarena.com/comment/industry-viewpoints-strategic-overview-and-risk-management-in-clinical-operations/20%Daily2018-12-10 15:54
https://www.clinicaltrialsarena.com/news/biosight-receives-approval-phase-llb-trial-bst-236-aml/20%Daily2018-07-11 23:00
https://www.clinicaltrialsarena.com/news/valbiotis-reports-positive-data-phase-ii-study-val-070/20%Daily2018-07-11 23:00
https://www.clinicaltrialsarena.com/news/miragen-begins-phase-ll-trial-mrg-201-keloid/20%Daily2018-07-11 23:00
https://www.clinicaltrialsarena.com/analysis/expert-insights-another-failure-for-bace1-drugs-raises-questions-about-alzheimers-disease-treatments/20%Daily2019-08-09 10:38
https://www.clinicaltrialsarena.com/news/seattle-genetics-completes-enrolment-ev-201-trial/20%Daily2018-07-10 23:00
https://www.clinicaltrialsarena.com/news/catabasis-initiate-polaris-dmd-trial-edasalonexent/20%Daily2018-07-10 23:00
https://www.clinicaltrialsarena.com/news/tetra-starts-phase-ll-trial-bpn14770-fragile-x-syndrome/20%Daily2018-07-10 23:00
https://www.clinicaltrialsarena.com/news/immune-response-antibiotic-resistant-bacteria/20%Daily2018-07-10 14:44
https://www.clinicaltrialsarena.com/analysis/pharmacovigilance-and-post-marketing-trials-stavudines-last-fight-part-iii/20%Daily2019-08-09 10:39
https://www.clinicaltrialsarena.com/news/aeromics-starts-phase-l-trial-aer-271-stroke/20%Daily2018-07-09 23:00
https://www.clinicaltrialsarena.com/news/galapagos-unveils-pinta-trial-design-ipf/20%Daily2018-07-09 23:00
https://www.clinicaltrialsarena.com/news/zynerba-begins-connect-fx-trial-fragile-x-syndrome/20%Daily2018-07-09 23:00
https://www.clinicaltrialsarena.com/news/eisai-biogen-report-positive-topline-phase-ii-data-ban2401/20%Daily2018-07-08 23:00
https://www.clinicaltrialsarena.com/news/janssen-reports-positive-results-approach-study-hiv/20%Daily2018-07-08 23:00
https://www.clinicaltrialsarena.com/news/orion-enrols-first-patient-refals-trial-levosimendan/20%Daily2018-07-08 23:00
https://www.clinicaltrialsarena.com/news/zynerba-reports-negative-data-phase-l-trial-zyn001/20%Daily2018-07-05 23:00
https://www.clinicaltrialsarena.com/news/deals-week-azurrx-biopharma-innovent-biologics-tosk/20%Daily2018-07-05 23:00
https://www.clinicaltrialsarena.com/news/mas-week-cosmos-holdings-akebia-therapeutics-biogen/20%Daily2019-08-12 09:38
https://www.clinicaltrialsarena.com/news/pivotal-apro-team-conduct-three-new-oncology-trials/20%Daily2018-07-05 23:00
https://www.clinicaltrialsarena.com/news/prana-doses-first-subject-phase-l-trial-pbt434/20%Daily2018-07-05 23:00
https://www.clinicaltrialsarena.com/comment/the-brexit-countdown-is-there-still-an-opportunity-for-conducting-clinical-trials-in-the-uk/20%Daily2018-12-10 16:01
https://www.clinicaltrialsarena.com/news/forendo-receives-mhra-approval-start-phase-l-trial-6219/20%Daily2019-08-12 09:39
https://www.clinicaltrialsarena.com/news/ipsen-reports-positive-results-celestial-trial-hcc/20%Daily2018-07-04 23:00
https://www.clinicaltrialsarena.com/analysis/2018-june-top-stories-drug/20%Daily2018-07-04 23:00
https://www.clinicaltrialsarena.com/news/cannabics-completes-trial-cannabics-sr-cacs/20%Daily2018-07-04 23:00
https://www.clinicaltrialsarena.com/comment/industry-viewpoints-manufacturing-imps-for-clinical-trials/20%Daily2022-04-18 13:53
https://www.clinicaltrialsarena.com/news/anavex-approval-phase-llb-lll-trial-anavex-2-73/20%Daily2018-07-03 23:00
https://www.clinicaltrialsarena.com/news/poxel-completes-enrolment-times-1-trial/20%Daily2018-07-03 23:00
https://www.clinicaltrialsarena.com/news/neovacs-reports-data-phase-iib-trial-ifn%ce%b1-kinoid/20%Daily2018-07-03 23:00
https://www.clinicaltrialsarena.com/analysis/pharmacovigilance-and-post-marketing-trials-stavudines-last-fight-part-ii/20%Daily2019-08-08 09:43
https://www.clinicaltrialsarena.com/news/genentech-reports-positive-results-impassion130-study/20%Daily2018-07-02 23:00
https://www.clinicaltrialsarena.com/news/ocugen-starts-phase-lll-trial-ocu300-ogvhd/20%Daily2018-07-02 23:00
https://www.clinicaltrialsarena.com/news/newlink-new-phase-l-positive-data-trial-dipg/20%Daily2018-07-02 23:00
https://www.clinicaltrialsarena.com/news/the-top-5-june-2018/20%Daily2018-12-10 16:07
https://www.clinicaltrialsarena.com/news/retrotope-receives-fda-approval-begin-phase-ll-lll-trial-rt001/20%Daily2018-07-01 23:00
https://www.clinicaltrialsarena.com/news/proqr-starts-enrolment-wings-trial-qr-313-deb/20%Daily2018-07-01 23:00
https://www.clinicaltrialsarena.com/news/arrowhead-reports-initial-positive-results-aroaat1001-trial/20%Daily2018-07-01 23:00